313 related articles for article (PubMed ID: 7778542)
1. Comparison of sestamibi single-photon emission computed tomography with positron emission tomography for estimating left ventricular myocardial viability.
Soufer R; Dey HM; Ng CK; Zaret BL
Am J Cardiol; 1995 Jun; 75(17):1214-9. PubMed ID: 7778542
[TBL] [Abstract][Full Text] [Related]
2. Assessment of myocardial viability in chronic coronary artery disease using technetium-99m sestamibi SPECT. Correlation with histologic and positron emission tomographic studies and functional follow-up.
Maes AF; Borgers M; Flameng W; Nuyts JL; van de Werf F; Ausma JJ; Sergeant P; Mortelmans LA
J Am Coll Cardiol; 1997 Jan; 29(1):62-8. PubMed ID: 8996296
[TBL] [Abstract][Full Text] [Related]
3. Myocardial viability in patients with chronic coronary artery disease. Comparison of 99mTc-sestamibi with thallium reinjection and [18F]fluorodeoxyglucose.
Dilsizian V; Arrighi JA; Diodati JG; Quyyumi AA; Alavi K; Bacharach SL; Marin-Neto JA; Katsiyiannis PT; Bonow RO
Circulation; 1994 Feb; 89(2):578-87. PubMed ID: 8313546
[TBL] [Abstract][Full Text] [Related]
4. Significance of defect severity in technetium-99m-MIBI SPECT at rest to assess myocardial viability: comparison with fluorine-18-FDG PET.
Altehoefer C; vom Dahl J; Biedermann M; Uebis R; Beilin I; Sheehan F; Hanrath P; Buell U
J Nucl Med; 1994 Apr; 35(4):569-74. PubMed ID: 8151377
[TBL] [Abstract][Full Text] [Related]
5. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
[TBL] [Abstract][Full Text] [Related]
6. Myocardial metabolic imaging by means of fluorine-18 deoxyglucose/technetium-99m sestamibi dual-isotope single-photon emission tomography.
Stoll HP; Hellwig N; Alexander C; Ozbek C; Schieffer H; Oberhausen E
Eur J Nucl Med; 1994 Oct; 21(10):1085-93. PubMed ID: 7828618
[TBL] [Abstract][Full Text] [Related]
7. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
[TBL] [Abstract][Full Text] [Related]
8. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects.
Sawada SG; Allman KC; Muzik O; Beanlands RS; Wolfe ER; Gross M; Fig L; Schwaiger M
J Am Coll Cardiol; 1994 Jan; 23(1):92-8. PubMed ID: 8277101
[TBL] [Abstract][Full Text] [Related]
10. Rest distribution of 99mTc-MIBI in patients with coronary artery disease assessed by SPECT: comparison with the distribution of [18F]FDG assessed by PET.
Gang H; Lucignani G; Landoni C; Galli L; Vanoli G; Rossetti C; Paganelli G; Fazio F
J Nucl Biol Med (1991); 1994 Dec; 38(4):540-4. PubMed ID: 7786915
[TBL] [Abstract][Full Text] [Related]
11. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of technetium 99m 2-methoxyisobutyl isonitrile single-photon emission computed tomography and isosorbide dinitrate infusion in assessment of myocardial viability before and after revascularization.
Li ST; Liu XJ; Lu ZL; Shi RF; Zhu XD; Chen WQ; Wu QW; Liu YZ
J Nucl Cardiol; 1996; 3(6 Pt 1):457-63. PubMed ID: 8989670
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
[TBL] [Abstract][Full Text] [Related]
14. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
[TBL] [Abstract][Full Text] [Related]
15. Effect of left ventricular function on the assessment of myocardial viability by technectium-99m sestamibi and correlation with positron emission tomography in patients with healed myocardial infarcts or stable angina pectoris, or both.
Arrighi JA; Ng CK; Dey HM; Wackers FJ; Soufer R
Am J Cardiol; 1997 Oct; 80(8):1007-13. PubMed ID: 9352969
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of regional myocardial perfusion in patients with severe left ventricular dysfunction: comparison of 13N-ammonia PET and 99mTc sestamibi SPECT.
Sand NP; Bøttcher M; Madsen MM; Nielsen TT; Rehling M
J Nucl Cardiol; 1998; 5(1):4-13. PubMed ID: 9504867
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 99mTc-sestamibi-18F-fluorodeoxyglucose dual isotope simultaneous acquisition and rest-stress 99mTc-sestamibi single photon emission computed tomography for the assessment of myocardial viability.
De Boer J; Slart RH; Blanksma PK; Willemsen AT; Jager PL; Paans AM; Vaalburg W; Piers DA
Nucl Med Commun; 2003 Mar; 24(3):251-7. PubMed ID: 12612465
[TBL] [Abstract][Full Text] [Related]
18. Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography.
Fragasso G; Chierchia SL; Lucignani G; Landoni C; Conversano A; Gilardi MC; Colombo F; Rossetti C; Fazio F
Am J Cardiol; 1993 Dec; 72(19):131G-139G. PubMed ID: 8279350
[TBL] [Abstract][Full Text] [Related]
19. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease.
Altehoefer C; Kaiser HJ; Dörr R; Feinendegen C; Beilin I; Uebis R; Buell U
Eur J Nucl Med; 1992; 19(5):334-42. PubMed ID: 1612095
[TBL] [Abstract][Full Text] [Related]
20. [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?
Srinivasan G; Kitsiou AN; Bacharach SL; Bartlett ML; Miller-Davis C; Dilsizian V
Circulation; 1998 Mar; 97(9):843-50. PubMed ID: 9521332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
